ENPP1 Affects Insulin Action and Secretion
Author Information
Author(s): Di Paola Rosa, Caporarello Nunzia, Marucci Antonella, Dimatteo Claudia, Iadicicco Claudia, Del Guerra Silvia, Prudente Sabrina, Sudano Dora, Miele Claudia, Parrino Cristina, Piro Salvatore, Beguinot Francesco, Marchetti Piero, Trischitta Vincenzo, Frittitta Lucia
Primary Institution: IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Italy
Hypothesis
The study aims to investigate the mechanisms through which ENPP1 affects insulin signaling, insulin secretion, and glucose metabolism.
Conclusion
ENPP1, particularly the Q121 variant, negatively impacts insulin signaling and glucose metabolism in liver, skeletal muscle, and pancreatic beta-cells.
Supporting Evidence
- ENPP1 expression was shown to impair insulin receptor activation.
- The Q121 variant exhibited a greater inhibitory effect on insulin signaling compared to the K121 variant.
- Insulin secretion was significantly reduced in beta-cells expressing the Q121 variant.
- Isolated human islets from QQ donors secreted approximately 50% less insulin compared to KK and KQ individuals.
Takeaway
This study found that a protein called ENPP1 can make it harder for the body to use insulin, especially when a specific version of this protein is present.
Methodology
The study involved transfecting ENPP1 variants into liver, muscle, and beta-cells and measuring insulin signaling and secretion.
Potential Biases
Potential biases may arise from the selection of cell lines and the specific experimental conditions used.
Limitations
The study primarily used in vitro models, which may not fully replicate in vivo conditions.
Participant Demographics
The study included isolated human islets from 85 non-diabetic brain-dead donors, with an average age of 58 years and 49.4% females.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website